Clinical Trial Update: Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing bortezomib with or without hormone therapy in relapsed prostate cancer; trial terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-11-05